Search

Your search keyword '"Kaitani, Ayako"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Kaitani, Ayako" Remove constraint Author: "Kaitani, Ayako"
36 results on '"Kaitani, Ayako"'

Search Results

1. Intranasal administration of ceramide liposome suppresses allergic rhinitis by targeting CD300f in murine models

2. The protective role of conjunctival goblet cell mucin sialylation

3. Orally desensitized mast cells form a regulatory network with Treg cells for the control of food allergy.

6. A nerve-goblet cell association promotes allergic conjunctivitis through the rapid antigen passage

7. Murine model identifies tropomyosin as IgE cross-reactive protein between house dust mite and coho salmon that possibly contributes to the development of salmon allergy

8. Staphylococcus aureus δ-toxin present on skin promotes the development of food allergy in a murine model

10. Leukocyte mono-immunoglobulin-like receptor 8 (LMIR8)/CLM-6 is an FcRγ-coupled receptor selectively expressed in mouse tissue plasmacytoid dendritic cells

11. Development of mouse model for oral allergy syndrome to identify IgE cross-reactive pollen and food allergens: ragweed pollen cross-reacts with fennel and black pepper

13. Mucosal Mast Cell–Specific Gene Expression Is Promoted by Interdependent Action of Notch and TGF-β Signaling

14. Pollen shells and soluble factors play non-redundant roles in the development of allergic conjunctivitis in mice

15. A Possible Association Between a Nucleotide‐Binding Domain LRR‐Containing Protein Family PYD‐Containing Protein 1 Mutation and an Autoinflammatory Disease Involving Liver Cirrhosis

16. Differential Lipid Recognition by Mouse versus Human CD300f, Inhibiting Passive Cutaneous Anaphylaxis, Depends on a Single Amino Acid Substitution in its Immunoglobulin-Like Domain

17. Notch signaling contributes to the establishment of sustained unresponsiveness to food allergens by oral immunotherapy

19. Identification of inhibitory mechanisms in pseudo-allergy involving Mrgprb2/MRGPRX2-mediated mast cell activation

22. CD300f is a potential therapeutic target for the treatment of food allergy

24. The phytosphingosine-CD300b interaction promotes zymosan-induced, nitric oxide–dependent neutrophil recruitment

25. CD300f is a potential therapeutic target for the treatment of food allergy.

26. The CD300e molecule in mice is an immune-activating receptor

27. Disrupting ceramide-CD300f interaction prevents septic peritonitis by stimulating neutrophil recruitment

28. Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation

30. Human CD300C Delivers an Fc Receptor-γ-dependent Activating Signal in Mast Cells and Monocytes and Differs from CD300A in Ligand Recognition

31. A Soluble Form of LMIR5/CD300b Amplifies Lipopolysaccharide-Induced Lethal Inflammation in Sepsis

32. Characterization of Leukocyte Mono-immunoglobulin-like Receptor 7 (LMIR7)/CLM-3 as an Activating Receptor

33. TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury

34. An Activating and Inhibitory Signal from an Inhibitory Receptor LMIR3/CLM-1: LMIR3 Augments Lipopolysaccharide Response through Association with FcRγ in Mast Cells

35. A nerve-goblet cell association promotes allergic conjunctivitis through rapid antigen passage.

36. Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation.

Catalog

Books, media, physical & digital resources